SECTORAL ASSET MANAGEMENT INC
CIK 1274413 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $143.3M
- Posisi
- 82
- Per tanggal
- 30 Juni 2026
#7.535 dari 9.443 berdasarkan nilai 13F · top 79.8%
Nilai portofolio QoQ: +18.7% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 39,65%
- Bobot 25 kepemilikan teratas
- 67,66%
- Posisi di atas 1%
- 35
- Jumlah posisi efektif
- 36,5
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 19,34% Perkiraan pembelian $40.599.966 · penjualan $25.527.088
Kepemilikan median: 4,0 kuartal Dilacak Q4 2024–Q2 2026 · 56,2% masih dipegang
- Posisi baru
- 15
- Meningkat
- 17
- Menurun
- 17
- Tertutup
- 10
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +41.1% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 99,3% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
96,5%
Lainnya/Tidak terpetakan
3,5%
Portofolio lengkap 82 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| CTNM Contineum Therapeutics, Inc. - Common stock | $11.925.151 | 8,32% | 727.587 | $2.422.865 | |||
| SI Shoulder Innovations, Inc. Common Stock | $8.728.654 | 6,09% | 430.407 | $2.474.840 | |||
| LLY Eli Lilly and Company Common Stock | $7.621.178 | 5,32% | 6.354 | $1.776.959 | |||
| UNH UnitedHealth Group Incorporated Common Stock (DE) | $5.500.863 | 3,84% | 13.235 | $1.453.648 | Turun ×1 | ||
| JNJ Johnson & Johnson Common Stock | $4.626.825 | 3,23% | 18.218 | $173.617 | |||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $3.995.903 | 2,79% | 41.987 | Naik ×1 | |||
| BNTX BioNTech SE - American Depositary Shares | $3.895.910 | 2,72% | 41.869 | $1.850.603 | Naik ×2 | ||
| DFTX Definium Therapeutics, Inc. - Common Shares | $3.683.702 | 2,57% | 78.310 | Naik ×1 | |||
| DXCM DexCom, Inc. - Common Stock | $3.418.417 | 2,39% | 50.756 | $1.959.510 | Naik ×1 | ||
| RCUS Arcus Biosciences, Inc. Common Stock | $3.418.122 | 2,39% | 110.870 | $2.382.618 | Naik ×1 | ||
| AMGN Amgen Inc. - Common Stock | $3.335.125 | 2,33% | 9.210 | $-179.857 | |||
| SMMT Summit Therapeutics Inc. - Common Stock | $3.208.023 | 2,24% | 220.180 | $1.808.396 | Naik ×1 | ||
| IRTC iRhythm Holdings, Inc. - Common Stock | $3.101.027 | 2,16% | 26.070 | Naik ×1 | |||
| ABBV AbbVie Inc. Common Stock | $3.070.008 | 2,14% | 12.200 | $416.630 | |||
| MRK Merck & Company, Inc. Common Stock (new) | $2.772.981 | 1,94% | 21.480 | $189.152 | |||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $2.745.954 | 1,92% | 79.043 | $2.025.524 | Naik ×1 | ||
| VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $2.698.237 | 1,88% | 5.432 | $-758.876 | Turun ×2 | ||
| ARGX argenx SE - American Depositary Shares | $2.626.517 | 1,83% | 2.831 | $-110.460 | Turun ×1 | ||
| GILD Gilead Sciences, Inc. - Common Stock | $2.605.131 | 1,82% | 20.620 | $-1.526.493 | Turun ×1 | ||
| INSM Insmed Incorporated - Common Stock | $2.475.290 | 1,73% | 23.216 | $-905.486 | Naik ×2 | ||
| TECX Tectonic Therapeutic, Inc. - Common Stock | $2.440.934 | 1,70% | 71.009 | $1.812.719 | Naik ×1 | ||
| ISRG Intuitive Surgical, Inc. - Common Stock | $2.326.428 | 1,62% | 5.850 | $-93.770 | Naik ×2 | ||
| IMTX Immatics N.V. - Ordinary Shares | $2.278.521 | 1,59% | 224.928 | $1.585.834 | Naik ×2 | ||
| SYK Stryker Corporation Common Stock | $2.248.893 | 1,57% | 7.129 | $318.755 | Naik ×1 | ||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $2.216.177 | 1,55% | 119.923 | Naik ×1 | |||
| CBIO Crescent Biopharma, Inc. - Common Stock | $2.183.400 | 1,52% | 121.300 | Naik ×1 | |||
| ROIV Roivant Sciences Ltd. - Common Shares | $2.162.329 | 1,51% | 61.100 | $1.145.961 | Naik ×1 | ||
| IQV IQVIA Holdings, Inc. Common Stock | $2.096.051 | 1,46% | 10.848 | $679.375 | Naik ×1 | ||
| PLSE Pulse Biosciences, Inc - Common Stock | $1.882.728 | 1,31% | 67.895 | Naik ×1 | |||
| DHR Danaher Corporation Common Stock | $1.830.726 | 1,28% | 9.597 | $11.135 | |||
| TMO Thermo Fisher Scientific Inc Common Stock | $1.759.926 | 1,23% | 3.508 | $35.639 | |||
| ABT Abbott Laboratories Common Stock | $1.640.579 | 1,14% | 18.080 | $-985.514 | Turun ×1 | ||
| ATEC Alphatec Holdings, Inc. - Common Stock | $1.608.035 | 1,12% | 185.900 | Naik ×1 | |||
| BSX Boston Scientific Corporation Common Stock | $1.550.564 | 1,08% | 36.330 | $-631.881 | Naik ×4 | ||
| TMDX TransMedics Group, Inc. - Common Stock | $1.457.919 | 1,02% | 21.950 | Naik ×1 | |||
| CYTK Cytokinetics, Incorporated - Common Stock | $1.391.153 | 0,97% | 16.330 | $846.539 | Naik ×2 | ||
| REGN Regeneron Pharmaceuticals, Inc. - Common Stock | $1.352.458 | 0,94% | 2.169 | $-1.129.262 | Turun ×3 | ||
| CVS CVS Health Corporation Common Stock | $1.344.850 | 0,94% | 13.000 | ||||
| EW Edwards Lifesciences Corporation Common Stock | $1.341.160 | 0,94% | 14.826 | $-47.267 | Turun ×1 | ||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $1.223.365 | 0,85% | 65.596 | $283.866 | Turun ×4 | ||
| BMY Bristol-Myers Squibb Company Common Stock | $1.218.663 | 0,85% | 21.150 | $-64.085 | |||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $1.097.337 | 0,77% | 25.573 | $12.696 | |||
| COGT Cogent Biosciences, Inc. - Common Stock | $1.034.838 | 0,72% | 26.740 | $132.440 | Naik ×1 | ||
| MDT Medtronic plc. Ordinary Shares | $876.345 | 0,61% | 11.100 | $-85.470 | |||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $836.158 | 0,58% | 13.285 | $-16.305 | Naik ×1 | ||
| KURA Kura Oncology, Inc. - Common Stock | $784.136 | 0,55% | 71.480 | $178.126 | |||
| CNC Centene Corporation Common Stock | $770.280 | 0,54% | 12.000 | ||||
| UTHR United Therapeutics Corporation - Common Stock | $742.307 | 0,52% | 1.370 | $-403.330 | Turun ×2 | ||
| HNGE Hinge Health, Inc. Class A Common Stock | $725.752 | 0,51% | 8.744 | $253.623 | Turun ×2 | ||
| NKTR Nektar Therapeutics - Common Stock | $705.849 | 0,49% | 10.111 | $-114.813 | Turun ×2 | ||
| ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | $695.379 | 0,49% | 2.310 | $-168.853 | |||
| Penerbit tidak dikenal (CUSIP: K08588103) | $685.470 | 0,48% | 2.570 | Naik ×1 | |||
| PFE Pfizer, Inc. Common Stock | $662.200 | 0,46% | 27.500 | $-110.000 | |||
| ARDX Ardelyx, Inc. - Common Stock | $624.209 | 0,44% | 122.394 | $-156.851 | |||
| PRVA Privia Health Group, Inc. - Common Stock | $621.019 | 0,43% | 24.136 | $62.831 | Turun ×1 | ||
| PTCT PTC Therapeutics, Inc. - Common Stock | $609.328 | 0,43% | 7.470 | $94.265 | Naik ×1 | ||
| IONS Ionis Pharmaceuticals, Inc. - Common Stock | $570.888 | 0,40% | 7.200 | $-46.352 | |||
| AGMB AgomAb Therapeutics NV - ADRs representing one common share. | $564.630 | 0,39% | 43.500 | $87.335 | |||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $540.729 | 0,38% | 9.450 | $-66.539 | |||
| ONC BeOne Medicines Ltd. - American Depositary Shares | $532.894 | 0,37% | 1.870 | $-98.167 | |||
| HUM Humana Inc. Common Stock | $497.299 | 0,35% | 1.250 | ||||
| JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | $421.698 | 0,29% | 1.750 | $50.404 | |||
| RPRX Royalty Pharma plc - Class A Ordinary Shares | $403.704 | 0,28% | 7.200 | $9.870 | |||
| BIIB Biogen Inc. - Common Stock | $399.711 | 0,28% | 1.850 | $13.801 | |||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $392.964 | 0,27% | 14.565 | $-502.171 | Turun ×4 | ||
| ILMN Illumina, Inc. - Common Stock | $374.870 | 0,26% | 2.132 | $78.799 | |||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $367.155 | 0,26% | 1.500 | $77.286 | |||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $342.765 | 0,24% | 15.680 | $-444.701 | Turun ×3 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $342.722 | 0,24% | 1.830 | $140.442 | |||
| ABVX Abivax SA - American Depositary Shares | $311.828 | 0,22% | 2.340 | $13.967 | |||
| BBIO BridgeBio Pharma, Inc. - Common Stock | $305.368 | 0,21% | 4.100 | $-381.908 | Turun ×4 | ||
| MRNA Moderna, Inc. - Common Stock | $304.631 | 0,21% | 4.350 | $56.727 | |||
| GH Guardant Health, Inc. - Common Stock | $297.059 | 0,21% | 1.980 | $91.536 | |||
| INCY Incyte Corporation - Common Stock | $266.396 | 0,19% | 2.350 | $12.272 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $254.505 | 0,18% | 23.500 | $-78.146 | |||
| SPRY ARS Pharmaceuticals, Inc. - Common Stock | $239.499 | 0,17% | 29.900 | $-437.173 | Turun ×1 | ||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $232.123 | 0,16% | 4.325 | $-478.682 | Turun ×3 | ||
| MEDP Medpace Holdings, Inc. - Common Stock | $227.724 | 0,16% | 430 | $-366 | |||
| TEM Tempus AI, Inc. - Class A Common Stock | $224.768 | 0,16% | 3.880 | ||||
| CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | $187.600 | 0,13% | 20.000 | Naik ×1 | |||
| PALI Palisade Bio, Inc. - Common Stock | $183.920 | 0,13% | 88.000 | $11.545 | |||
| Penerbit tidak dikenal (CUSIP: 29286X101) | $37.541 | 0,03% | 21.700 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
| Sekuritas | Nilai | % dari portofolio | Rentetan |
|---|---|---|---|
| BSX | $1.550.564 | 1,08% | naik ×4 |
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| ORKA | $3.995.903 | 41.987 | 2,79% |
| DFTX | $3.683.702 | 78.310 | 2,57% |
| IRTC | $3.101.027 | 26.070 | 2,16% |
| AVTX | $2.216.177 | 119.923 | 1,55% |
| CBIO | $2.183.400 | 121.300 | 1,52% |
| PLSE | $1.882.728 | 67.895 | 1,31% |
| ATEC | $1.608.035 | 185.900 | 1,12% |
| TMDX | $1.457.919 | 21.950 | 1,02% |
| CVS | $1.344.850 | 13.000 | 0,94% |
| CNC | $770.280 | 12.000 | 0,54% |
| Penerbit tidak dikenal (CUSIP: K08588103) | $685.470 | 2.570 | 0,48% |
| HUM | $497.299 | 1.250 | 0,35% |
| TEM | $224.768 | 3.880 | 0,16% |
| CRBP | $187.600 | 20.000 | 0,13% |
| Penerbit tidak dikenal (CUSIP: 29286X101) | $37.541 | 21.700 | 0,03% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| SI | Hanya pergerakan harga | +0 | +$2.5M |
| CTNM | Hanya pergerakan harga | +0 | +$2.4M |
| RCUS | Beli lebih banyak | +66K | +$2.4M |
| AVBP | Beli lebih banyak | +49K | +$2.0M |
| DXCM | Beli lebih banyak | +28K | +$2.0M |
| BNTX | Beli lebih banyak | +20K | +$1.9M |
| TECX | Beli lebih banyak | +52K | +$1.8M |
| SMMT | Beli lebih banyak | +151K | +$1.8M |
| LLY | Hanya pergerakan harga | +0 | +$1.8M |
| IMTX | Beli lebih banyak | +158K | +$1.6M |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| LENZ | 30 Sep. 2025 | 977.245 | $28.643.051 | -89,7% |
| EVMN | 30 Juni 2026 | 589.005 | $13.541.225 | 8,9% |
| ANAB | 31 Des. 2025 | 194.485 | $5.955.131 | 19,8% |
| BCAX | 31 Des. 2025 | 266.495 | $4.207.956 | 49,8% |
| SLDB | 31 Des. 2025 | 633.052 | $3.905.931 | 64,6% |
| MBX | 31 Des. 2025 | 194.898 | $3.410.715 | 111,4% |
| XBI | 31 Des. 2025 | 34.000 | $3.406.800 | Tidak lagi dilacak |
| ZBIO | 31 Des. 2025 | 152.025 | $3.374.955 | -17,7% |
| PVLA | 31 Des. 2025 | 49.115 | $3.079.019 | 37,8% |
| TIL | 31 Des. 2025 | 161.380 | $2.882.247 | -32,8% |
| REPL | 30 Sep. 2025 | 231.650 | $2.152.029 | 240,1% |
| MDT | 30 Juni 2025 | 23.850 | $2.143.161 | 8,0% |
| TRML | 30 Sep. 2025 | 116.510 | $1.862.995 | Tidak lagi dilacak |
| AZN | 31 Maret 2026 | 15.232 | $1.400.277 | -17,2% |
| SRPT | 31 Maret 2025 | 11.020 | $1.339.922 | -70,0% |
| THC | 30 Juni 2025 | 9.000 | $1.210.500 | 55,8% |
| HCAT | 31 Maret 2025 | 160.000 | $1.131.200 | -62,5% |
| SWTX | 30 Juni 2025 | 25.325 | $1.117.592 | Tidak lagi dilacak |
| MRUS | 31 Des. 2025 | 11.545 | $1.086.962 | Tidak lagi dilacak |
| PRVA | 31 Maret 2025 | 52.000 | $1.016.600 | -4,3% |
| BPMC | 30 Juni 2025 | 11.235 | $994.410 | Tidak lagi dilacak |
| CVS | 31 Maret 2025 | 22.000 | $987.580 | 38,8% |
| VTYX | 31 Maret 2026 | 96.945 | $875.413 | Tidak lagi dilacak |
| PHR | 30 Juni 2025 | 34.000 | $869.040 | -58,0% |
| RAPP | 30 Juni 2026 | 25.421 | $835.005 | 16,7% |
| GMED | 30 Sep. 2025 | 13.500 | $796.770 | 54,0% |
| NARI | 31 Maret 2025 | 15.153 | $773.561 | Tidak lagi dilacak |
| BOLD | 30 Juni 2026 | 678.574 | $746.431 | 15,6% |
| ASND | 30 Juni 2026 | 2.800 | $728.276 | -2,8% |
| ICLR | 30 Juni 2025 | 4.000 | $699.960 | 21,6% |
| LEGN | 30 Sep. 2025 | 19.627 | $696.562 | -31,2% |
| LENZ | 31 Maret 2026 | 42.500 | $680.000 | -47,3% |
| CNC | 30 Sep. 2025 | 12.500 | $678.500 | 79,2% |
| CLOV | 30 Juni 2025 | 183.000 | $656.970 | 51,6% |
| ELV | 30 Juni 2025 | 1.500 | $652.440 | 1,5% |
| CI | 31 Maret 2025 | 2.250 | $621.315 | -15,4% |
| FOLD | 31 Maret 2026 | 43.300 | $616.592 | Tidak lagi dilacak |
| IOVA | 31 Maret 2025 | 81.500 | $603.100 | 148,3% |
| CARL | 31 Maret 2026 | 47.700 | $589.095 | 70,4% |
| EW | 31 Maret 2025 | 7.850 | $581.136 | 26,6% |
| KMTS | 30 Sep. 2025 | 35.000 | $580.300 | 15,7% |
| CI | 31 Des. 2025 | 1.800 | $518.850 | 1,1% |
| QURE | 30 Juni 2026 | 29.245 | $499.411 | 4,0% |
| BMY | 31 Des. 2025 | 10.800 | $487.080 | 23,8% |
| ALHC | 30 Juni 2026 | 26.911 | $474.172 | -45,2% |
| COGT | 30 Juni 2025 | 79.020 | $473.330 | 405,0% |
| RDNT | 30 Juni 2026 | 7.999 | $447.064 | 23,4% |
| CVRX | 30 Sep. 2025 | 73.500 | $432.180 | -65,1% |
| ZLAB | 31 Des. 2025 | 12.590 | $426.675 | 48,4% |
| ITCI | 31 Maret 2025 | 4.900 | $409.248 | Tidak lagi dilacak |
| HUM | 31 Maret 2025 | 1.581 | $401.116 | 44,7% |
| INSP | 30 Juni 2026 | 7.225 | $372.666 | 38,3% |
| SRRK | 30 Sep. 2025 | 10.380 | $367.660 | 48,8% |
| SGOV | 30 Juni 2025 | 3.589 | $361.323 | -0,1% |
| OLMA | 31 Maret 2025 | 61.650 | $359.420 | 191,2% |
| NBIX | 30 Juni 2026 | 2.300 | $343.841 | -8,1% |
| OMDA | 30 Juni 2026 | 25.620 | $322.043 | 12,2% |
| RCKT | 30 Juni 2025 | 44.383 | $296.035 | 43,9% |
| TEM | 31 Maret 2026 | 4.500 | $265.725 | 46,7% |
| TSBX | 31 Maret 2025 | 517.648 | $257.219 | Tidak lagi dilacak |
| RVMD | 30 Sep. 2025 | 6.240 | $229.570 | 349,8% |
| GERN | 31 Maret 2025 | 63.500 | $224.790 | -1,6% |
| CAI | 30 Sep. 2025 | 8.350 | $223.112 | -21,6% |
| MDGL | 31 Maret 2026 | 352 | $204.984 | 2,4% |
| NVO | 30 Juni 2025 | 2.850 | $197.904 | -32,6% |
| CRNX | 30 Juni 2025 | 5.710 | $191.513 | 194,5% |
| VTRS | 30 Sep. 2025 | 19.800 | $176.814 | 63,4% |
| MEDP | 30 Sep. 2025 | 531 | $166.660 | 20,1% |
| IOBT | 30 Sep. 2025 | 117.691 | $163.590 | Tidak lagi dilacak |
| PCVX | 31 Des. 2025 | 4.205 | $151.464 | 33,5% |
| CRSP | 30 Sep. 2025 | 2.540 | $123.546 | -11,3% |
| CRGX | 31 Maret 2025 | 8.500 | $122.570 | Tidak lagi dilacak |
| EXEL | 31 Maret 2025 | 3.500 | $116.550 | 46,8% |
| ARVN | 30 Juni 2025 | 12.930 | $90.769 | 28,7% |
| RXRX | 30 Sep. 2025 | 11.500 | $58.190 | -31,3% |
| ENGN | 30 Juni 2025 | 11.700 | $52.416 | -50,4% |
| MLTX | 31 Des. 2025 | 956 | $6.855 | 24,2% |